Although studies such as Dapas and Dunaif have highlighted the genomic underpinnings of PCOS, our findings suggest that sortilin does not significantly alter lipid metabolism in PCOS patients, as evidenced by the lack of a strong correlation between sortilin and lipid parameters beyond LDL-C [27]. This evidence concerns the gene SORT1 and polycystic ovary syndrome.